Neuberger Berman High Yield Strategies Fund Plans Monthly Dividend of $0.09 (NYSEAMERICAN:NHS)

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) announced a monthly dividend on Monday, August 31st. Shareholders of record on Tuesday, September 15th will be paid a dividend of 0.0905 per share by the investment management company on Wednesday, September 30th. This represents a c) annualized dividend and a yield of 18.3%. The ex-dividend date of this dividend is Tuesday, September 15th.

Neuberger Berman High Yield Strategies Fund Stock Performance

Shares of NYSEAMERICAN NHS opened at $5.95 on Tuesday. The stock’s 50 day moving average price is $6.08 and its two-hundred day moving average price is $6.49. Neuberger Berman High Yield Strategies Fund has a 52-week low of $5.91 and a 52-week high of $7.75.

Institutional Investors Weigh In On Neuberger Berman High Yield Strategies Fund

Several institutional investors and hedge funds have recently made changes to their positions in NHS. EP Wealth Advisors LLC acquired a new position in Neuberger Berman High Yield Strategies Fund in the second quarter worth $71,000. Cura Wealth Advisors LLC bought a new position in shares of Neuberger Berman High Yield Strategies Fund in the 2nd quarter worth about $77,000. Mercer Global Advisors Inc. ADV acquired a new position in shares of Neuberger Berman High Yield Strategies Fund in the 3rd quarter valued at about $80,000. Integrity Advisory Solutions LLC acquired a new position in shares of Neuberger Berman High Yield Strategies Fund in the 4th quarter valued at about $81,000. Finally, XTX Topco Ltd bought a new stake in shares of Neuberger Berman High Yield Strategies Fund during the 2nd quarter valued at about $113,000.

Neuberger Berman High Yield Strategies Fund Company Profile

The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.

Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.